Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.
BG Medicine, Inc. (NASDAQ: BGMD) shares surged 20.87 percent to close at $1.39 a share Tuesday. The stock traded between $1.24 and $1.57 on volume 8.86 million shares traded. The company has announced positive results from a clinical research study of VIDAS Galectin-3 were published online ahead of print in the journal Clinica Chimica Acta. Shares of BG Medicine have gained over 30.0 percent year-to-date.
Get more information on BG Medicine and free access to the in-depth equity report at:
Echelon Corporation (NASDAQ: ELON) shares jumped 19.09 percent to close at $3.68 a share Tuesday. The stock traded between $2.95 and $3.70 on volume 2.12 million shares traded. The company is scheduled to release results for the fourth quarter of 2013 after market close on Thursday, February 6th. Shares of Echelon have gained over 70.0 percent year-to-date.
Get more information on Echelon free access to the in-depth equity report at:
Kraton Performance Polymers Inc. (NYSE: KRA) shares gained 15.61 percent to close at $24.73 a share Tuesday. The stock traded between $24.42 and $25.44 on volume 1.16 million shares traded. The company has agreed to combine with the styrenic block copolymer operations of Taiwan-based LCY Chemical Corp. Shares of Kraton Performance Polymers are up approximately 7.0 percent year-to-date.
Get more information on Kraton and free access to the in-depth equity report at:
Lantronix Inc. (NASDAQ: LTRX) shares spiked 23.56 percent to close at $2.57 a share Tuesday. The stock traded between $1.98 and $2.62 on volume of 1.05 million shares traded. The company is scheduled to release results for the second quarter of fiscal 2014 after market close on Thursday, January 30th. Shares of Lantronix have gained approximately 65.0 percent year-to-date.
Get more information on Lantronix and free access to the in-depth equity report at:
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.
Five Star Equities